BioCentury
ARTICLE | Company News

NeoPath, Bayer Diagnostics deal

July 19, 1999 7:00 AM UTC

The companies will combine NPTH’s visual intelligence technology with Bayer’s antibodies to develop an automated screening system to detect early lung cancer using sputum samples. The companies expect...